Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Amifostine
Therapeutic Area : Oncology
Study Phase : Phase II
Sponsor : Merro Pharmaceutical
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Amifostine is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Nasopharyngeal Neoplasms.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 07, 2013
Lead Product(s) : Amifostine
Therapeutic Area : Oncology
Highest Development Status : Phase II
Sponsor : Merro Pharmaceutical
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Amifostine
Therapeutic Area : Gastroenterology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine
Details : Amifostine is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Stomatitis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 02, 2011
Lead Product(s) : Amifostine
Therapeutic Area : Gastroenterology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable